Optum and Change Healthcare have completed their merger initiated in 2021; efficacy of the Jynneos vaccine is in question after 90 of 7339 individuals contracted monkeypox after vaccination; the CDC will no longer maintain a list of country-by-country COVID-19 travel advisories.
Read More
Periostin as Biomarker May Be More Useful Than Eosinophils in ECRS
October 4th 2022Despite extensive study, eosinophilic chronic rhinosinusitis (ECRS) remains a significant health problem with few effective treatments, so this study compared periostin levels among those who did and did not have ECRS to assess its potential as a disease biomarker.
Read More
Medicare Part B Pricing Changes Aimed at Encouraging Biosimilar Use Begin
October 3rd 2022One of the first parts of the landmark Inflation Reduction Act took effect Monday; it boosts the add-on payment for qualifying biosimilars whose average sales price is not more than the price of its reference product from 6% of the reference product’s ASP to 8% for 5 years.
Read More
Community-Based Cycling Program Shows Positive Impact on Symptom Management in Parkinson Disease
October 3rd 2022Location, cost, and transportation were cited as important factors regarding adherence and satisfaction with community-based exercise programs among patients with Parkinson disease.
Read More
High-Dose, Extended Duration Aflibercept Injections Benefit Patients With DME, nAMD
October 3rd 2022Results from the pivotal PHOTON and PULSAR trials highlighted the success of 8-mg aflibercept every 12 or 16 weeks in patients with diabetic macular edema (DME) and neovascular age-related macular degeneration (nAMD).
Read More
Dr Amresh Raina: Cancer Treatments Are Affecting Heart Function in Many Ways
October 3rd 2022Amresh Raina, MD, director of the Advanced Heart Failure and Pulmonary Hypertension Program at Allegheny General Hospital and the Allegheny Health Network in Pittsburgh, Pennsylvania, is a board-certified advanced heart failure cardiologist, who is also certified in echocardiography and general cardiology.
Watch
Svante Pääbo was awarded the Nobel Prize in Physiology or Medicine for his discoveries in human evolution; the amyotrophic lateral sclerosis (ALA drug AMX0035 was priced at $158,000 per year or about $12,500 per 28-day prescription; more than 16,000 Americans died of combination cancer and COVID-19 in the first 10 months of the pandemic.
Read More
In AAO Lecture, AMA CEO Discusses How the Organization Is Addressing Areas of Innovation
October 3rd 2022During a lecture delivered at the American Academy of Ophthalmology (AAO) annual meeting, James Madara, MD, CEO of the American Medical Association, discussed 3 areas in ophthalmology care that required innovation to effectively push care into the 21st century.
Read More
Family Medicine Doctors, AI Could Be Effective in DR Screening
October 3rd 2022Posters presented at AAO 2022 found that family medicine doctors and artificial intelligence (AI) were able to screen patients for diabetic retinopathy (DR) effectively, although false negatives in AI need to be improved.
Read More
Most Patients in China With Lung Cancer Experience Financial Toxicity
October 3rd 2022A new report finds despite reforms to the country’s health care system, many patients in China with lung cancer experience stress, and sometimes health consequences, on account of the disease’s financial burden.
Read More
T&E Regimen, Consistent Adherence Important to Management of nAMD
October 2nd 2022Posters presented at the American Academy of Ophthalmology 2022 annual meeting show that the treat-and-extend (T&E) regimen was effective in managing neovascular age-related macular degeneration (nAMD), which makes adherence to treatment vital for long-term outcomes.
Read More
Dr Stephen Schleicher: Culture, People, Analytics Contributed to OCM Success
October 2nd 2022Co-hosted by Memorial Sloan Kettering Cancer Center, the most recent Institute for Value-Based Medicine® event took place on September 22, with a focus on improving cancer care delivery through innovation.
Watch
Which DME Drug to Try First? Patients on Bevacizumab Can Successfully Transition to Aflibercept
October 2nd 2022The presentation focused on the Protocol AC trial, which considered whether step therapy had an impact on visual outcomes for patients starting on bevacizumab and switching to aflibercept later.
Read More
Posters Emphasize Prevalence and Need for Prompt Treatment of RVO
September 30th 2022Posters presented at the American Academy of Ophthalmology 2022 annual meeting showed that patients with retinal vein occlusion (RVO) are most likely older with higher diastolic blood pressure, and they require prompt treatment to help manage the disease.
Read More
Panel Reviews Health Inequities and Opportunities for Innovation Through Population Health Delivery
September 30th 2022A panel discussion at the 70th Annual Roy A. Bowers Pharmaceutical Conference addressed recent care delivery initiatives in New Jersey that aim to address health inequities and other population health concerns.
Read More
AAO Panel Offers Insight on Treatment Recommendations, In-Office Retina Surgery
September 30th 2022Speakers at a panel at the American Academy of Ophthalmology (AAO) 2022 conference spoke about future treatment options for patients in both minimally proven operations and in-office retina surgeries.
Read More
Advanced Imaging System Investigated for Faster Diagnosis of Skin Cancers
September 30th 2022This new study explored the diagnostic utility and accuracy of 2-photon fluorescence microscopy (TPFM) among nonmelanoma skin cancers, which included basal cell carcinoma and squamous cell carcinoma.
Read More
Dr Melissa O'Connor Reviews Considerations for Discharge in Home Health
September 30th 2022Melissa O'Connor, PhD, MBA, RN, FGSA, FAAN, endowed professor in Community and Home Health Nursing, M. Louise Fitzpatrick School of Nursing, Villanova University, and director, Gerontology Interest Group, discussed several factors for clinicians to consider in creating plans to discharge adults from skilled home health care.
Watch